Medifast (0K05) Financial Statements
Medifast Financial Overview
Medifast's market cap is currently $135.87M. The company's EPS TTM is $-3.69; its P/E ratio is -3.29; and it has a dividend yield of 8.17%. Medifast is estimated to report earnings on February 23, 2027, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 385.79M | $ 602.46M | $ 1.07B | $ 1.60B | $ 1.53B |
| Gross Profit | $ 275.19M | $ 444.62M | $ 775.85M | $ 1.14B | $ 1.13B |
| Operating Income | $ -14.21M | $ 2.88M | $ 126.40M | $ 184.81M | $ 216.24M |
| EBITDA | $ 8.60M | $ 16.49M | $ 141.90M | $ 195.74M | $ 222.94M |
| Net Income | $ -18.67M | $ 2.09M | $ 99.42M | $ 143.57M | $ 164.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 167.27M | $ 162.34M | $ 150.04M | $ 87.69M | $ 109.54M |
| Total Assets | $ 257.01M | $ 284.21M | $ 309.91M | $ 316.21M | $ 398.33M |
| Total Debt | $ 16.79M | $ 16.13M | $ 22.01M | $ 26.05M | $ 32.54M |
| Net Debt | $ -72.52M | $ -74.80M | $ -72.43M | $ -61.64M | $ -71.64M |
| Total Liabilities | $ 58.09M | $ 74.10M | $ 108.43M | $ 161.17M | $ 195.85M |
| Stockholders' Equity | $ 198.92M | $ 210.11M | $ 201.48M | $ 155.04M | $ 202.47M |
| Cash Flow | |||||
| Free Cash Flow | $ 1.25M | $ 17.02M | $ 141.17M | $ 177.89M | $ 60.34M |
| Operating Cash Flow | $ 6.86M | $ 24.48M | $ 147.66M | $ 194.57M | $ 94.55M |
| Investing Cash Flow | $ -7.93M | $ -26.52M | $ -61.05M | $ -11.41M | $ -29.06M |
| Financing Cash Flow | $ -564.00K | $ -1.51M | $ -79.79M | $ -199.58M | $ -125.13M |
Currency in USD